Timeliness of MMR vaccination - Influence on vaccination coverage

Vaccine

Volumn 22, Issue 31-32, 2004, Pages 4228-4232

  Dannetun, Eva ^a,b   Tegnell, Anders ^b   Hermansson, Göran ^c   Törner, Anna ^b   Giesecke, Johan ^b  

^a Sandbacksgatan 5 SE 581 91 ^*  (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c Central Unit of Child Health Care   (Sweden)

Author keywords

Measles; Pre school children; Vaccination coverage

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEASLES; MUMPS; PARENTAL BEHAVIOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RECORDING; RUBELLA; SWEDEN; VACCINATION;

AGE FACTORS; CHILD, PRESCHOOL; DATA COLLECTION; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MASS IMMUNIZATION; MEASLES-MUMPS-RUBELLA VACCINE; POPULATION SURVEILLANCE; SWEDEN;

EID: 4944258171     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.04.018     Document Type: Article

References (19)

1. De Serres G., Gay N.J., Farrington C.P. Epidemiology of transmissible diseases after elimination. Am. J. Epidemiol. 151:2000;1039-1048
2. Hamburger H, Hartvig Christiansen A, Glismann S. Measles outbreak in North Jutland, Denmark. Eurosurveillance Wkly 2002;6(6).
3. Cronin M, Fitzsimmons GJ. Measles outbreak in the Republic of Ireland. Eurosurveillance Wkly 2000; 4 (37) (update).
4. Measles outbreaks in Germany. Eurosurveillance Wkly 2002;6(12).
5. New measles epidemic in southern Italy: 1217 cases reported to sentinel surveillance, January-May 2003. Eurosurveillance Wkly 2003;7(27).
6. Measles outbreak, the Netherlands. Wkly Epidemiol. Rec. 2000;5:119-21.
7. Anderson R.M., May R.M. Vaccination and herd immunity of infectious diseases. Nature. 318:1985;323-329
8. Hutchins SS, Redd SC, Scharg S, et al. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994. Med. Gen. Med. 2001;Jan 24:E5.
9. Ramsay M.E., Jin L., White J., Litton P., Cohen B., Brown D. The elimination of indigenous measles transmission in England and Wales. J. Infect. Dis. 187(Suppl 1):2003;198-207
10. Van den Hof S., Berbers G., de Melker H., Conyn-van Spaendonk M. Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage. Vaccine. 18:2000;931-940
11. De Serres G., Joly J.R., Fauvel M., Meyer F., Masse B., Boulianne N. Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles. Vaccine. 15:1997;620-623
12. Heijbel H., Jefferson T. Vaccine safety - improving monitoring. Vaccine. 19:2001;2457-2460
13. Laubereau B., Hermann M., Schmitt H.J., Weil J., Von Kries R. Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol. Infect. 128:2002;185-192
14. Hull B.P., McIntyre P.B., Heath T.C., Sayer G.P. Measuring immunisation coverage in Australia. A review of Australian childhood immunisation register. Aust. Family Phys. 28:1999;55-60
15. http://www.hpa.org.uk/cdr/archive04/immunisation04.htm#COVER_jul_sep. Accessed on 19 April 2004.
16. Janaszek W., Slusarczyk J. Immunity against measles in populations of women and infants in Poland. Vaccine. 20:2003;2948-2953
17. Atkinson W.L., Hadler S.C., Redd S.B., Orenstein W.A. Measles surveillance - United States, 1991. MMWR CDC Surveill. Summ. 41:1992;1-12
18. The National Vaccine Advisory Committee. The measles epidemic: the problems, barriers, and recommendations. JAMA 1991;266:1547-52.
19. Siedler A., Hermann M., Schmitt H.-J., Von Kries R. Consequences of delayed measles vaccination in Germany. Pediatr. Infect. Dis. J. 21:2002;826-830